[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1974

Sleep Amphetamine Effects in MBDS and Normal Subjects

Author Affiliations

From the San Francisco Veterans Administration Hospital and the University of California at San Francisco (Drs. Feinberg and Westerman, and Messrs. Hibi and Cavness); and the Downstate Medical Center, Brooklyn, NY (Dr. Small and Ms. Braun). Dr. Westerman is now with the Monterey County Community Mental Health Service, Calif; and Dr. Small with The Children's Service, Bellevue Psychiatric Hospital, New York.

Arch Gen Psychiatry. 1974;31(5):723-731. doi:10.1001/archpsyc.1974.01760170107017

Electroencephalographic sleep patterns in children with minimal brain dysfunction syndrome (MBDS or hyperkinesis) before and during stimulant treatment differed little from those of age-matched controls. It is unlikely that the therapeutic mechanisms of amphetamines in MBDS are exerted on or reflected in physiological sleep patterns.

Neither MBDS children nor normal young adults showed withdrawal elevations of rapid eye movement (REM) sleep after administration of amphetamines in constant dosage. Young adults showed REM rebounds only when the dosage was increased prior to withdrawal.

In contrast to sedative-hypnotics, stimulant drugs do not reduce eye movement activity during REM sleep. This difference is emphasized for the specificity hypothesis-that different classes of psychoactive drugs differentially alter physiological sleep patterns—would be untenable if sedatives and stimulants produced the same effects on sleep.